GetTopicDetailResponse(id=74e818333c, topicName=ACEI, introduction=ACEI, content=null, image=null, comments=2, allHits=2562, url=https://h5.medsci.cn/topic?id=1833, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=1318, tagList=[TagDto(tagId=1318, tagName=ACEI)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2264224, encodeId=c0412264224db, content=<a href='/topic/show?id=74e818333c' target=_blank style='color:#2F92EE;'>#ACEI#</a> <a href='/topic/show?id=07f25183043' target=_blank style='color:#2F92EE;'>#心血管疾病#</a>, objectTitle=ACEI還是心血管疾病治療的基石嗎?深入解讀《ACEI在心血管疾病防治中應(yīng)用的專家共識》, objectType=article, longId=873227, objectId=6ff48e3227ba, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240517/1715939995328_5579292.png, objectUrl=/article/show_article.do?id=6ff48e3227ba, replyNumber=0, likeNumber=30, createdTime=2025-05-09, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=6ff48e3227ba, moduleTitle=ACEI還是心血管疾病治療的基石嗎?深入解讀《ACEI在心血管疾病防治中應(yīng)用的專家共識》, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=6ff48e3227ba)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2144640, encodeId=dc8c2144640f5, content=<a href='/topic/show?id=1c1710265113' target=_blank style='color:#2F92EE;'>#高血壓#</a><a href='/topic/show?id=74e818333c' target=_blank style='color:#2F92EE;'>#ACEI#</a>、<a href='/topic/show?id=c24e2e2076' target=_blank style='color:#2F92EE;'>#ARB#</a>和<a href='/topic/show?id=577b4195fe' target=_blank style='color:#2F92EE;'>#CCB#</a>都能降低主要<a href='/topic/show?id=38c451e4317' target=_blank style='color:#2F92EE;'>#心血管事件#</a>的風(fēng)險。<a href='/topic/show?id=573332291bd' target=_blank style='color:#2F92EE;'>#利尿劑#</a>表現(xiàn)出類似的趨勢,而β-受體阻滯劑和腎素抑制劑則沒有。就依從性而言,ARB和CCB與安慰劑相當(dāng),而ACEI、<a href='/topic/show?id=6ebe1918eb0' target=_blank style='color:#2F92EE;'>#β-受體阻滯劑#</a>和<a href='/topic/show?id=ab6b19130b3' target=_blank style='color:#2F92EE;'>#α-受體阻滯劑#</a>與安慰劑和其他藥物相比明顯更容易出現(xiàn)中止治療。, objectTitle=ESH 2023 重磅開啟 | 一文盡覽!多項高血壓重磅研究結(jié)果公布!, objectType=article, longId=778450, objectId=d670e784505c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20230619/50a9c31b1fcd4b97bc867ef7fe6e7093.jpg, objectUrl=/article/show_article.do?id=d670e784505c, replyNumber=1, likeNumber=212, createdTime=2023-06-25, rootId=0, userName=俠膽醫(yī)心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=d670e784505c, moduleTitle=ESH 2023 重磅開啟 | 一文盡覽!多項高血壓重磅研究結(jié)果公布!, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d670e784505c)], followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=950537, encodeId=4e6095053ed9, content=<a href='/topic/show?id=74e818333c' target=_blank style='color:#2F92EE;'>#ACEI#</a>治療與<a href='/topic/show?id=0a2e6153302' target=_blank style='color:#2F92EE;'>#杜氏肌營養(yǎng)不良癥#</a>,原理是什么?, objectTitle=Eur Heart J:預(yù)防性ACEi治療與杜氏肌營養(yǎng)不良癥患者總體生存率之間的關(guān)聯(lián), objectType=article, longId=208918, objectId=f491208918f8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021323/1616496984429_1739456.png, objectUrl=/article/show_article.do?id=f491208918f8, replyNumber=0, likeNumber=194, createdTime=2021-03-23, rootId=0, userName=病毒獵手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f491208918f8, moduleTitle=Eur Heart J:預(yù)防性ACEi治療與杜氏肌營養(yǎng)不良癥患者總體生存率之間的關(guān)聯(lián), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f491208918f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29